The Chemopreventive Potential of Diosmin and Hesperidin for COVID-19 and Its Comorbid Diseases

Rohmad Yudi Utomo, Muthi' Ikawati, Dyaningtyas Dewi Pamungkas Putri, Irfani Aura Salsabila, Edy Meiyanto

Abstract


The COVID-19 becomes worse with the existence of comorbid diseases such as cardiovascular diseases, metabolic syndromes, inflammation, degenerative diseases, as well as cancer. Therefore, a comprehension approach is needed to combat such comorbid conditions, not only focusing on the virus infection and replication but also directed to prevent the raising comorbid symptoms. This study analyzed the potential natural compounds, especially diosmin and hesperidin, as an anti-SARS-CoV-2 and chemopreventive agent against several COVID-19 comorbid diseases by using an in-silico method. Diosmin and hesperidin together with other natural compounds and existing viral drugs (lopinavir, nafamostat, and comastat) were docked into several proteins involved in SARS-CoV-2 infection and replication namely SARS-CoV-2 protease (PDB:6LU7), spike glycoprotein-RBD (PDB:6LXT), TMPRSS2, and PD-ACE2 (PDB:6VW1) using MOE software. The interaction properties were determined under docking score values. The result exhibited that diosmin and hesperidin performed superior interaction with all the four proteins compared to the other compounds, including the existing drugs. Moreover, under literature study, diosmin and hesperidin also elicit good chemopreventive properties against cardiovascular disorder, lung and kidney degeneration, as well as cancer development. In conclusion, diosmin and hesperidin possess high opportunity to be used for the COVID-19 and its the comorbid diseases as chemopreventive agents.


Keywords: chemoprevention, COVID-19, diosmin, hesperidin, SARS-CoV-2 infection


Full Text:

PDF

References


Abd-Elhakim, Y.M., Ghoneim, M.H., Ebraheim, L.L. and Imam, T.S., 2020, Taurine and hesperidin rescues carbon tetrachloride-triggered testicular and kidney damage in rats via modulating oxidative stress and inflammation, Life Sciences, 254, 117782. CrossRef

Abdel-Daim, M.M., Khalifa, H.A., Abushouk, A.I., Dkhil, M.A. and Al-Quraishy, S.A., 2017, Diosmin attenuates methotrexate-induced hepatic, renal, and cardiac injury: a biochemical and histopathological study in mice, Oxidative medicine and cellular longevity, 2017, 3281670. CrossRef

Afar, D.E., Vivanco, I., Hubert, R.S., Kuo, J., Chen, E., Saffran, D.C., Raitano, A.B. and Jakobovits, A., 2001, Catalytic cleavage of the androgen-regulated TMPRSS2 protease results in its secretion by prostate and prostate cancer epithelia, Cancer research, 61(4), 1686-1692.

Cao, B., Wang, Y., Wen, D., Liu, W., Wang, J., Fan, G., et. al., 2020, A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19, N Engl J Med., 382(19), 1787-1799. CrossRef

Chan, J.F., Kok, K., Zhu, Z., Chu, H., To, K.K., Yuan, S., et. al., 2020, Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan, Emerging Microbes & Infections, 9(1), 221-236. CrossRef

Chang, Y., Tung, Y., Lee, K., Chen, T., Hsiao, Y., Chang, H., Hsieh, T., et al., 2020, Potential therapeutic agents for COVID-19 based on the analysis of protease and RNA polymerase docking, Preprints, 2020, 2020020242. CrossRef

Chen, H. and Du, Q., 2020, Potential natural compounds for preventing 2019-nCoV infection, Preprints, 2020, 202001.0358.v1.

Da’i, M., Meilinasary, K. A., Suhendi, A. and Haryanti, S., 2019, Selectivity Index of Alpinia galanga Extract and 1’-Acetoxychavicol Acetate on Cancer Cell Lines, Indonesian Journal of Cancer Chemoprevention, 10(2), 95-100. CrossRef

Darmawan, E. and Pramono, S., 2016, Essential Oil of Javanese Turmeric (Curcuma xanthorrhiza, Roxb) Decrease Level of LDL-Cholesterol and Body Weight in Rats, Indonesian Journal of Cancer Chemoprevention, 7(1), 6-8. CrossRef

de Lucena, T., Silva Santos, A.F., de Lima, B.R., de Albuquerque Borborema, M.E. and de Azevêdo Silva, J., 2020, Mechanism of inflammatory response in associated comorbidities in COVID-19, Diabetes & metabolic syndrome, 14(4), 597–600.

Folegatti, P.M., Ewer, K.J., Aley, P.K., Angus, B., Becker, S., Belij-Rammerstorfer, S., et. al., 2020, Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial, Lancet, 396(10249), 467-478. CrossRef

Guan, W.J., Liang, W.H., Zhao, Y., Liang, H.R., Chen, Z.S., Li, Y.M., et al., 2020, Comorbidity and its impact on 1590 patients with Covid-19 in China: A Nationwide Analysis, European Respiratory Journal, 55(5), 2000547. CrossRef

Harrison, C., 2020, Coronavirus puts drug repurposing on the fast track, Nature Biotechnology, 38, 379-381. CrossRef

Hsu, C.C., Lin, M.H., Cheng, J.T. and Wu, M.C., 2017, Diosmin, a citrus nutrient, activates imidazoline receptors to alleviate blood glucose and lipids in type 1-like diabetic rats, Nutrients, 9(7), 684.

Hussain, M., Jabeen, N., Amanullah, A., Baig, A.A., Aziz, B., Shabbir, S., Raza, F. and Uddin, N., 2020, Molecular docking between human TMPRSS2 and SARS-CoV-2 spike protein: conformation and intermolecular interactions, AIMS microbiology, 6(3), 350.

Ikawati, M., Armandari, I., Khumaira, A. and Ertanto, Y., 2019, Effects of peel extract from Citrus reticulata and hesperidin, a citrus flavonoid, on macrophage cell line, Indonesian J Pharm, 30(4), 260-268. CrossRef

Iqbal, M.M., Abid, I., Hussain, S., Shahzad, N., Waqas, M.S. and Iqbal, M.J., 2020, The effects of regional climatic condition on the spread of COVID-19 at global scale, The Science of the total environment, 739, 140101. CrossRef

Islam, J., Shree, A., Afzal, S.M., Vafa, A. and Sultana, S., 2020, Protective effect of Diosmin against benzo (a) pyrene‐induced lung injury in Swiss Albino Mice, Environmental Toxicology, 35(7), 747-757.

Kongtawelert, P., Wudtiwai, B., Shwe, T.H., Pothacharoen, P. and Phitak, T., 2020, Inhibitory effect of Hesperidin on the expression of programmed death ligand (PD-L1) in breast Cancer, Molecules, 25(2), 252.

Lee, C.J., Wilson, L., Jordan, M.A., Nguyen, V., Tang, J. and Smiyun, G., 2010, Hesperidin suppressed proliferations of both Human breast cancer and androgen‐dependent prostate cancer cells, Phytotherapy Research, 24(S1), S15-S19.

Meiyanto, E. and Larasati, Y.A., 2019, The chemopreventive activity of Indonesia medicinal plants targeting on hallmarks of cancer, Advanced Pharmaceutical Bulletin, 9(2), 219-230. CrossRef

Meneguzzo, F., Ciriminna, R., Zabini, F. and Pagliaro, M., 2020, Review of Evidence Available on Hesperidin-Rich Products as Potential Tools against COVID-19 and Hydrodynamic Cavitation-Based Extraction as a Method of Increasing Their Production, Processes, 8, 549.

Meyer, J.J.M., Afoloyan, A.J., Taylor, M.B. and Erasmus, D., 1997, Antiviral activity of galangin isolated from the aerial parts of Helichrysum aureonitens, Journal of Ethnopharmacology, 56, 165-169.

Murray, A.S., Varela, F.A. and List, K., 2016, Type II transmembrane serine proteases as potential targets for cancer therapy, Biological chemistry, 397(9), 815–826. CrossRef

Nogata, Y., Sakamoto, K., Shiratsuchi, H., Ishii, T., Yano, M. and Ohta, H., 2006, Flavonoid composition of fruit tissues of citrus species, Bioscience Biotechnology & Biochemistry, 70(1), 178-192. CrossRef

Parvathaneni, V. and Gupta, V., 2020, Utilizing drug repurposing against COVID-19 - Efficacy, limitations, and challenges, Life sciences, 259, 118275. CrossRef

Plaze, M., Attali, D., Petit, A.C., Blatzer, M., Simon-Loriere, E., Vinckier, F., et. al., 2020, Repurposing chlorpromazine to treat COVID-19: The reCoVery study, Encephale, 46(3), 169-172. CrossRef

Pushkaran, A.C., Vinod, V., Vanuopadath, M., Nair, S.S., Nair, S.V., Vasudevan, A.K.,Biswas, R. and Mohan, C.G., 2019, Combination of repurposed drug diosmin with amoxicillin-clavulanic acid causes synergistic inhibition of mycobacterial growth, Scientific reports, 9(1), 1-14.

Roser, M. and Ritchie, H., 2020, Coronavirus Disease (COVID-19). Published online at OurWorldInData.org. Retrieved from: ‘https://ourworldindata.org/coronavirus’ [Online Resource]

Saad, S., Ahmad, I., Kawish, S.M., Khan, U.A., Ahmad, F.J., Ali, A. and Jain, G.K., 2020, Improved cardioprotective effects of hesperidin solid lipid nanoparticles prepared by supercritical antisolvent technology, Colloids and Surfaces B: Biointerfaces, 187, 110628.

Sakai, K., Ami, Y., Tahara, M., Kubota, T., Anraku, M., Abe, M., Nakajima, N., et al., 2014, The host protease TMPRSS2 plays a major role in in vivo replication of emerging H7N9 and seasonal influenza viruses, Journal of virology, 88(10), 5608–5616. CrossRef

Salehi, B., Fokou, P.V.T., Sharifi-Rad, M., Zucca, P., Pezzani, R., Martins, N., et al., 2019, The therapeutic potential of naringenin: a review of clinical trials, Pharmaceuticals, 12, 11. CrossRef

Shalkami, A.S., Hassan, M.I.A. and Bakr, A.G., 2018, Anti-inflammatory, antioxidant and anti-apoptotic activity of diosmin in acetic acid-induced ulcerative colitis, Human and experimental toxicology, 37(1), 78-86.

Tabeshpour, J., Hosseinzadeh, H., Hashemzaei, M. and Karimi, G., 2020, A review of the hepatoprotective effects of hesperidin, a flavanon glycoside in citrus fruits, against natural and chemical toxicities, DARU Journal of Pharmaceutical Sciences, 1-13.

Tahir, U.Q.M, Alqahtani, S.M., Alamri, M.A. and Chen, L.L., 2020, Structural basis of SARS-CoV-2 3CL(pro) and anti-COVID-19 drug discovery from medicinal plants, J Pharm Anal., 10(4), 313-319. CrossRef

Thunders, M. and Delahunt, B., 2020, Gene of the month: TMPRSS2 (transmembrane serine protease 2), Journal of clinical pathology, 2020-206987. CrossRef

Utomo, R.Y., Ikawati, M. and Meiyanto, E., 2020, Revealing the Potency of Citrus and Galangal Constituents to Halt SARS-CoV-2 Infection, Preprints, 2020, 2020030214. CrossRef

Wang, J., 2020, Fast identification of possible drug treatment of coronavirus disease-19 (COVID-19)through computational drug repurposing study, ChemRxiv. CrossRef

Wrapp, D., Wang, N., Corbett, K.S., Goldsmith, J.A., Hsieh, C., Abiona, O., Graham, B.S., McLellan, J.S., 2020, Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation, Science, 367(6483), 1260-1263. CrossRef

Zaragozá, C., Villaescusa, L., Monserrat, J., Zaragozá, F. and Álvarez-Mon, M., 2020, Potential therapeutic anti-inflammatory and immunomodulatory effects of dihydroflavones, flavones, and flavonols, Molecules, 25(4), 1017.

Zhu, F.C., Li, Y.H., Guan, X.H., Hou, L.H., Wang, W.J., Li, J.X., et. al., 2020, Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a dose-escalation, open-label, non-randomised, first-in-human trial, Lancet, 395(10240), 1845-1854. CrossRef

Zmora, P., Moldenhauer, A.S., Hofmann-Winkler, H. and Pöhlmann, S., 2015, TMPRSS2 isoform 1 activates respiratory viruses and is expressed in viral target cells, PloS one, 10(9), e0138380.




DOI: http://dx.doi.org/10.14499/indonesianjcanchemoprev11iss3pp154-167

Copyright (c) 2020 Rohmad Yudi Utomo, Muthi' Ikawati, Dyaningtyas Dewi Pamungkas Putri, Irfani Aura Salsabila, Edy Meiyanto

Indexed by:

               

               

      

 

Indonesian Society for Cancer Chemoprevention